Sol-Gel Technologies (NASDAQ: SLGL) is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Our current product candidate pipeline consists of late-stage branded product candidates that leverage our proprietary silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.
Our unique technology platform was designed to enable drug substances to be entrapped in porous silica microcapsules in order to address the limitations of topical drug delivery by stabilizing active drug ingredients, extending drug delivery time and reducing potential irritation caused by direct application to the skin.
For more information, please visit www.Sol-Gel.com
Our unique technology platform was designed to enable drug substances to be entrapped in porous silica microcapsules in order to address the limitations of topical drug delivery by stabilizing active drug ingredients, extending drug delivery time and reducing potential irritation caused by direct application to the skin.
For more information, please visit www.Sol-Gel.com
Location: Israel, Center District, Ness Ziona
Employees: 51-200
Founded date: 1997
Investors 1
| Date | Name | Website |
| - | Arkin Hold... | arkinholdi... |
Mentions in press and media 11
| Date | Title | Description |
| 13.03.2024 | Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments | - |
| 09.11.2021 | Sol-Gel Technologies Announces Sale of Generic Dermatology Portfolio to Partner Padagis for $21 Million - Form 6-K | Sol-Gel Technologies Announces Sale of Generic Dermatology Portfolio to Partner Padagis for $21 Million - Sol-Gel to receive $21 million over 24 months in exchange for the transfer of its rights to two marketed generic drugs and eight unapp... |
| 04.11.2021 | Sol-Gel Technologies Announces Sale of Generic Dermatology Portfolio to Partner Padagis for $21 Million | - Sol-Gel to receive $21 million over 24 months in exchange for the transfer of its rights to two marketed generic drugs and eight unapproved generic programs - Sol-Gel to retain two generic programs encompassing four high-value generic dru... |
| 04.11.2021 | Sol-Gel Technologies Announces Sale of Generic Dermatology Portfolio to Partner Padagis for $21 Million | - Sol-Gel to receive $21 million over 24 months in exchange for the transfer of its rights to two marketed generic drugs and eight unapproved generic programs - Sol-Gel to retain two generic programs encompassing four high-value generic dru... |
| 30.06.2021 | Sol Gel Technologies : Gel Investor Conference Call Presentation.pdf | NASDAQ: SLGL June 2021 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are... |
| 01.06.2021 | Sol Gel Technologies : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS (Form 6-K) | NOTICE OF ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON JULY 8, 2021 ________________________ Dear Sol-Gel Technologies Ltd. Shareholders: We cordially invite you to attend an Annual Meeting of Shareholders, or the Meeting, of Sol-Gel Techno... |
| 01.06.2021 | SOL-GEL TECHNOLOGIES LTD. Sol Gel Technologies : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS (Form 6-K) | NOTICE OF ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON JULY 8, 2021 ________________________ Dear Sol-Gel Technologies Ltd. Shareholders: We cordially invite you to attend an Annual Meeting of Shareholders, or the Meeting, of Sol-Gel Techno... |
| 25.05.2021 | Sol Gel Technologies : TO BE HELD ON JULY 8, 2021 ________________________ (Form 6-K) | TO BE HELD ON JULY 8, 2021 ________________________ Dear Sol-Gel Technologies Ltd. Shareholders: We cordially invite you to attend an Annual Meeting of Shareholders, or the Meeting, of Sol-Gel Technologies Ltd., or the Company, to be held a... |
| 25.05.2021 | SOL-GEL TECHNOLOGIES LTD. Sol Gel Technologies : TO BE HELD ON JULY 8, 2021 ________________________ (Form 6-K) | TO BE HELD ON JULY 8, 2021 ________________________ Dear Sol-Gel Technologies Ltd. Shareholders: We cordially invite you to attend an Annual Meeting of Shareholders, or the Meeting, of Sol-Gel Technologies Ltd., or the Company, to be held a... |
| 24.01.2018 | Term Sheet — Wednesday, January 24 | 5 Qs WITH A DEALMAKER Four years ago, Arlan Hamilton was living out of a hotel room that she shared with her mom. At that point, she had given up a career as a live music production coordinator to become a venture capitalist. There were a f... |
Show more